Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to evaluate the role of duloxetine in controlling pain after radical mastectomy.
Inadequate control of postoperative pain is associated with increased length of hospital stay, increased hospital cost, sleep disturbance, depression, functional impairment and affects the quality of life.
Modified is one of the commonly performed procedures which is associated with severe postoperative pain.
Preemptive analgesia is the analgesic treatment initiated before the surgical procedure to prevent central sensitization from the noxious stimuli. Drugs such as gabapentin, pregabalin, serotonin-norepinephrine reuptake inhibitors, dexamethasone, and cyclooxygenase-2 inhibitors have been used for preemptive analgesia.
There are contrary results about the role of duloxetine in mangement of acute postoperative pain.
Arecent meta-analysis was done in 2020 that concluded that the currently available evidence does not support the clinical use of duloxetine for the management of acute postoperative pain,so we will discuss that in this study.
There are many studies that have shown that perioperative use of duloxetine for a few days has a significant effect on reducing postoperative pain and analgesic requirements.
Duloxetine is a dual anti-depressant drug that inhibits the neuronal reuptake of serotonin (5-HT) and norepinephrine (NE) modulating the descending inhibitory pain pathways by increasing the availability of serotonin and norepinephrine. Duloxetine is an approved drug for the treatment of post-traumatic depression, major depression, and generalized anxiety disorder. It is also approved for the treatment of various chronic painful syndromes, including neuropathic pain associated with diabetes, chronic musculoskeletal pain, and fibromyalgia.
The mechanisms of action so far described suggest that duloxetine may be useful as an adjunct in the treatment of acute postoperative pain.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Acetaminophen group | Experimental | patients will receive intravenous 500 mg acetaminophen(every 6 hours postoperatively. |
|
| Duloxetine group | Experimental | Patients will receive duloxetine 30 mg every 12 hours for 3 days before surgery, 30 mg 2 hours preoperatively and 30 mg 12 hours postoperatively and intravenous 500 mg acetaminophen (every 6 hours postoperatively) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Acetaminophen group | Procedure | patients will receive intravenous 500 mg acetaminophen(every 6 hours postoperatively |
|
| Measure | Description | Time Frame |
|---|---|---|
| Total morphine consumption | Postoperative Total morphine consumption will be recorded | 48 hours postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| First analgesic request | First analgesic request will be recorded | 24 hours postoperatively |
| Post-operative pain | Post-operative pain will be assessed by visual analogue score (VAS) from 0-10 scale 0 (no pain) to 10 (the worst imaginable pain) at 2,4,6 h then every 6h |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Known Allergies to duloxetine.
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dina Elfeky, M.B.B.CH. | Contact | 0 111 747 2680 | +2 | dena154452@med.tanta.edu.eg |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Tanta University hospitals | Recruiting | Tanta | Elgarbia | Egypt |
Data will be available under a reasonable request from the corresponding author
one year after the end of the study
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Duloxetine group | Procedure | Patients will receive duloxetine 30 mg every 12 hours for 3 days before surgery, 30 mg 2 hours preoperatively and 30 mg 12 hours postoperatively and intravenous 500 mg acetaminophen every 6 hours postoperatively |
|
| 48 hours postoperatively. |
| Heart rate | Heart rate will be measured every 30 minutes intraoperative and at 0 hour (direct postoperative) at post anesthesia care unit then at 2,4,6 hours at ward then every 6 hours for 48 hours postoperatively | 48 hours postoperatively |
| Mean arterial blood pressure | Mean arterial blood pressure will be measured every 30 minutes intraoperative and at 0 hour (direct postoperative) at post anesthesia care unit then at 2,4,6 hours at ward then every 6 hours for 48 hours postoperatively | 48 hours postoperatively |
| Adverse effects | Hypotension, Bradycardia, nausea, dry mouth,diarrhea, constipation,insomnia, somnolence, fatigue, hyperhidrosis and pruritus will be observed and treated accordingly | 48 hours postoperatively |